By Staff
Tuesday, October 26, 2021 12:24 AM
LAVAL, QC and ALPHARETTA, Ga.—
Bausch + Lomb, a global eye health business of Bausch Health Companies Inc. (NYSE/TSX: BHC) and
Clearside Biomedical, Inc. (Nasdaq: CLSD) announced Monday that the U.S. Food and Drug Administration (FDA) has approved the drug Xipere (triamcinolone acetonide injectable suspension) for suprachoroidal use for the treatment of macular edema associated with uveitis, a form of eye inflammation. "With this FDA approval, Xipere is the first and only therapy available in the United States that utilizes the suprachoroidal space to treat patients suffering from macular edema associated with uveitis, which is the leading cause of vision loss in people with uveitis," said Joseph C. Papa, chairman and CEO, Bausch Health.
By Staff
Tuesday, October 26, 2021 12:21 AM
SEATTLE, Wash.—
Kubota Vision Inc., a clinical-stage specialty ophthalmology company and a wholly-owned subsidiary of Kubota Pharmaceutical Holdings Co., Ltd. (Tokyo 4596), announced that the company received Quality Management System - ISO 13485:2016 certification for the design and development of ophthalmic medical devices.
By Staff
Tuesday, October 26, 2021 12:18 AM
MIAMI—
Bascom Palmer Eye Institute of the University of Miami
Miller School of Medicine announced that Christopher J. Kaler has received a Research to Prevent Blindness (RPB) Medical Student Eye Research Fellowship that will allow him to take a year off from medical school and to devote that time to pursue a research project at Bascom Palmer.
By Staff
Friday, October 22, 2021 12:21 AM
SEATTLE, BOSTON and TOKYO—
Aurion Biotech, which is developing novel treatments for preventing blindness, has formed a medical advisory board composed of eminent ophthalmologists. The board will collaborate with the company’s executive team in clinical development, and is chaired by Edward Holland, MD, who was recently appointed as Aurion Biotech's chief medical advisor. “The doctors on this board are among the best in our field,” said Dr. Holland. “Their expertise, commitment to, and enthusiasm for Aurion Biotech’s cell therapy speak volumes about the transformational potential of this treatment to cure blindness resulting from corneal endothelial disease. I welcome their contributions. It’s a privilege to work closely with each of them.”
By Staff
Thursday, October 21, 2021 12:33 AM
SOUTHLAKE, Texas—
Retina Consultants of America (RCA), a comprehensive physician management services organization, has added
Colorado Retina Associates (CRA) to its national consortium. With the addition of Colorado Retina, RCA adds a key partner in the Rocky Mountain Region and expands its footprint into a new territory, according to an announcement Wednesday. CRA was founded in 2006 through the merger of three independent practices and has grown to include 13 board-certified and fellowship-trained ophthalmologists in the greater Denver-Boulder metropolitan area.
By Staff
Thursday, October 21, 2021 12:27 AM
NEW YORK—
Mount Sinai Health System has launched the first eye stroke service in New York City to expedite the diagnosis and treatment of patients who arrive at the emergency room with eye stroke—a medical emergency that must be addressed as quickly as possible to prevent irreversible vision loss.
By Staff
Tuesday, October 12, 2021 12:21 AM
LOS ANGELES—
Nvision Eye Centers, one of the larger providers of comprehensive eyecare, LASIK and cataract surgery services in the U.S., has acquired a majority interest in
East West Eye Institute (EWEI), one of the largest independent eyecare platforms in California, according to an announcement by the investment banking firm Intrepid.
By Staff
Thursday, October 7, 2021 12:21 AM
WALTHAM, Mass.—
BVI, a diversified global ophthalmic device company, announced an investment in
Beyeonics Vision, a medical technology subsidiary of Elbit Systems Ltd. (NASDAQ: ESLT and TASE: ESLT).
By Staff
Wednesday, October 6, 2021 12:24 AM
GARDEN CITY, N.Y.—
Spectrum Vision Partners has announced that Comprehensive Eye MD in Floral Park, N.Y., and its team of eyecare specialists are joining Spectrum’s leading
OCLI Vision Group, a multi-practice ophthalmology group located across the Northeast.
By Staff
Monday, October 4, 2021 12:21 AM
SARASOTA, Fla.—
US Eye, a leading group of patient-centric, vertically integrated multi-specialty physician practices, has announced that Dr. Lowrey King, founder of
The Retina Center of Charleston, has joined the US Eye network.
By Staff
Thursday, September 30, 2021 12:24 AM
PARIS and CAMBRIDGE, Mass.—
Eyevensys, a privately held, clinical-stage biotechnology company developing non-viral gene therapies for ophthalmic diseases, has entered into strategic engagements with U.S.-based medical device manufacturers
Phillips-Medisize and
Minnetronix Medical to develop the next generation of the company’s core technology.
By Staff
Tuesday, September 28, 2021 12:21 AM
ANNAPOLIS, Md.—
Vision Innovation Partners, a leading eyecare platform, said Monday that it has acquired
See Clearly Vision, a premier eyecare practice with locations in Tysons Corner and Arlington, Va.
By Staff
Tuesday, September 21, 2021 12:33 AM
SARASOTA, Fla.—
US Eye, a physician-led network of eyecare practices backed by a mid-market North Carolina investment firm, said this week that it has expanded its practice base to 50 clinics and five surgery centers across the southeastern U.S. The US Eye practice network, headquartered here, has recently completed partnerships with
Griffey Eye Care of Chesapeake, Va.;
Albemarle Eye Center in northeastern North Carolina; and
Sungate Medical Group in Hilton Head Island, S.C., according to the US Eye announcement.